Tumour stem cells and drug resistance - PubMed (original) (raw)
Review
doi: 10.1038/nrc1590.
Affiliations
- PMID: 15803154
- DOI: 10.1038/nrc1590
Review
Tumour stem cells and drug resistance
Michael Dean et al. Nat Rev Cancer. 2005 Apr.
Abstract
The contribution of tumorigenic stem cells to haematopoietic cancers has been established for some time, and cells possessing stem-cell properties have been described in several solid tumours. Although chemotherapy kills most cells in a tumour, it is believed to leave tumour stem cells behind, which might be an important mechanism of resistance. For example, the ATP-binding cassette (ABC) drug transporters have been shown to protect cancer stem cells from chemotherapeutic agents. Gaining a better insight into the mechanisms of stem-cell resistance to chemotherapy might therefore lead to new therapeutic targets and better anticancer strategies.
Similar articles
- [Tumor stem cells and drug resistance].
Ou Y, Guo XL. Ou Y, et al. Sheng Li Ke Xue Jin Zhan. 2007 Apr;38(2):115-9. Sheng Li Ke Xue Jin Zhan. 2007. PMID: 17633223 Review. Chinese. - Overcoming Multidrug Resistance in Cancer Stem Cells.
Moitra K. Moitra K. Biomed Res Int. 2015;2015:635745. doi: 10.1155/2015/635745. Epub 2015 Nov 16. Biomed Res Int. 2015. PMID: 26649310 Free PMC article. Review. - Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.
Moitra K, Lou H, Dean M. Moitra K, et al. Clin Pharmacol Ther. 2011 Apr;89(4):491-502. doi: 10.1038/clpt.2011.14. Epub 2011 Mar 2. Clin Pharmacol Ther. 2011. PMID: 21368752 - Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells.
Xu M, Gong A, Yang H, George SK, Jiao Z, Huang H, Jiang X, Zhang Y. Xu M, et al. Cancer Lett. 2015 Dec 1;369(1):124-33. doi: 10.1016/j.canlet.2015.08.005. Epub 2015 Aug 11. Cancer Lett. 2015. PMID: 26276718 - Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z, Gabrisova V, Kucerova L. Kozovska Z, et al. Biomed Pharmacother. 2014 Oct;68(8):911-6. doi: 10.1016/j.biopha.2014.10.019. Epub 2014 Oct 30. Biomed Pharmacother. 2014. PMID: 25458789 Review.
Cited by
- CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5.
Nengroo MA, Maheshwari S, Singh A, Verma A, Arya RK, Chaturvedi P, Saini KK, Singh AK, Sinha A, Meena S, Gupta A, Mishra A, Sarkar J, Datta D. Nengroo MA, et al. Cell Death Dis. 2021 May 8;12(5):464. doi: 10.1038/s41419-021-03730-8. Cell Death Dis. 2021. PMID: 33966046 Free PMC article. - Cancer Stem Cells: Detection and Characterization from Solid Tumors.
Rehman A, Panda SK, Tirino V, Del Vecchio V. Rehman A, et al. Methods Mol Biol. 2024;2835:215-228. doi: 10.1007/978-1-0716-3995-5_18. Methods Mol Biol. 2024. PMID: 39105918 - Targeted Heating of Mitochondria Greatly Augments Nanoparticle-Mediated Cancer Chemotherapy.
Xu J, Shamul JG, Wang H, Lin J, Agarwal P, Sun M, Lu X, Tkaczuk KHR, He X. Xu J, et al. Adv Healthc Mater. 2020 Jul;9(14):e2000181. doi: 10.1002/adhm.202000181. Epub 2020 Jun 17. Adv Healthc Mater. 2020. PMID: 32548935 Free PMC article. - Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C, Yan Z, Cao X, Zhang X, Yang L. Li C, et al. J Mol Neurosci. 2016 Oct;60(2):145-56. doi: 10.1007/s12031-016-0783-y. Epub 2016 Jun 25. J Mol Neurosci. 2016. PMID: 27343059 - Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R, Rofstad EK. Huang R, et al. Oncotarget. 2017 May 23;8(21):35351-35367. doi: 10.18632/oncotarget.10169. Oncotarget. 2017. PMID: 27343550 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources